| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/20/2003 | US20030036059 Methods, kits and compositions pertaining to PNA Molecular Beacons |
| 02/20/2003 | US20030036058 Amplification of hybridization in sample; obtain sample, incubate with primer, expose to modified monitor hybridization, compare to control |
| 02/20/2003 | US20030036057 Diagnosing cardiovascular disorders; obtain sample, extract nucleotide sequences, incubate with allelic probe, detect hybridization, presence of signal indicates cardiovascular disorder |
| 02/20/2003 | US20030036056 Inhibitors and target molecule co-localization |
| 02/20/2003 | US20030036053 Process for typing HCV isolates |
| 02/20/2003 | US20030036052 Sensor for analyzing components of fluids |
| 02/20/2003 | US20030036051 Methods of screening for antagonists and agonists of polypeptides having kinase functions |
| 02/20/2003 | US20030036049 Testing drug sensitivity of cells; obtain cells, culture, incubate with test drug, expose to probe, detect signal, determine drug sensitivity |
| 02/20/2003 | US20030035109 Device and method for detecting organic molecules in a test substance |
| 02/20/2003 | US20030034993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | DE19923182C2 Mittel zur Detektion von Phageninfektionen in Fermentationen mit rekombinanten Escherichia coli Means for detection of phage infections in fermentations with recombinant Escherichia coli |
| 02/20/2003 | CA2808328A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2790951A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2460215A1 Haplotype map of the human genome and uses therefor |
| 02/20/2003 | CA2457448A1 Human smooth muscle myosin heavy chain |
| 02/20/2003 | CA2457437A1 A novel cancer marker and uses therefor in the diagnosis of cancer |
| 02/20/2003 | CA2457424A1 Molecular interactions in cells |
| 02/20/2003 | CA2457391A1 Device and methods for detecting the response of a plurality of cells to at least one analyte of interest |
| 02/20/2003 | CA2457059A1 System for detecting protease |
| 02/20/2003 | CA2456942A1 Compositions and methods for modulation of darpp-32 phosphorylation |
| 02/20/2003 | CA2456928A1 Cellular virus receptors and methods of use |
| 02/20/2003 | CA2456882A1 Modified cyclic nucleotide gated ion channel (cng) comprising methionine or valine substitutions at t537 and uses thereof |
| 02/20/2003 | CA2456786A1 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | CA2456765A1 Nucleic acid field effect transistor |
| 02/20/2003 | CA2456719A1 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof |
| 02/20/2003 | CA2456708A1 Crystal forms and mutants of rank ligand |
| 02/20/2003 | CA2456590A1 Biological assay detection method |
| 02/20/2003 | CA2456571A1 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 02/20/2003 | CA2456568A1 Method for identification of type specific polynucleotide sequences |
| 02/20/2003 | CA2456565A1 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/20/2003 | CA2456546A1 Method and diagnostic kit for diagnosing helicobacter pylori |
| 02/20/2003 | CA2456369A1 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | CA2456271A1 Use of lysyl oxidase inhibitors for cell culture and tissue engineering |
| 02/20/2003 | CA2456117A1 Chimeric protein and its use in electron transfer methods |
| 02/20/2003 | CA2456099A1 Improved method and composition for determining resistance to an acetohydroxyacid synthase inhibitor |
| 02/20/2003 | CA2456058A1 Method for identifying proteins with n-terminal n-myristoylation |
| 02/20/2003 | CA2456010A1 Phosphorylated histone h2b as an apoptosis marker |
| 02/20/2003 | CA2455962A1 G protein-coupled receptor assay |
| 02/20/2003 | CA2455336A1 Peptides that bind to atherosclerotic lesions |
| 02/20/2003 | CA2455161A1 Method and nucleic acids for the analysis of colon cancer |
| 02/20/2003 | CA2454766A1 A screening method for variations in human myh associated with a predisposition towards colorectal cancer |
| 02/20/2003 | CA2454648A1 Irinotecan for treatment of cancer |
| 02/20/2003 | CA2454647A1 Method for determining susceptibility to prion disease |
| 02/20/2003 | CA2454643A1 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 02/20/2003 | CA2454640A1 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 02/20/2003 | CA2454637A1 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 02/20/2003 | CA2454627A1 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 02/20/2003 | CA2454519A1 Hprp4s as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | CA2454514A1 Sphks as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2453914A1 Rapid and specific detection of campylobacter |
| 02/20/2003 | CA2453913A1 Method for identifying substances which positively influence inflammatory conditions |
| 02/20/2003 | CA2453248A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | CA2452478A1 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | CA2451691A1 Use of r-nsaid compounds for anti-hiv treatment |
| 02/20/2003 | CA2428822A1 Modulators of p-selectin glycoprotein ligand 1 |
| 02/19/2003 | WO2002016574A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 02/19/2003 | EP1284423A2 Adrenic acid (delta 7,10,13,16 docosatetraenoic acid ) receptor and uses thereof |
| 02/19/2003 | EP1284421A1 Method of constructing polynucleotide microarray, apparatus for the construction and polynucleotide microarray |
| 02/19/2003 | EP1284298A2 Identification and use of molecules implicated in pain |
| 02/19/2003 | EP1284297A2 Identification and use of molecules implicated in pain |
| 02/19/2003 | EP1284296A1 Method for the detection of minority genomes in virus quasispecies using dna microchips |
| 02/19/2003 | EP1284289A1 Method of examining allergic disease |
| 02/19/2003 | EP1284284A2 Cell culture model for arteriosclerosis |
| 02/19/2003 | EP1283985A2 Method and apparatus for patch-clamp measurements on cells |
| 02/19/2003 | EP1283911A2 Method for detecting and characterising activity of proteins involved in lesion and dna repair |
| 02/19/2003 | EP1283910A1 Tgf beta-rii promoter polymorphisms |
| 02/19/2003 | EP1283909A1 High density protein arrays for screening of protein activity |
| 02/19/2003 | EP1283908A1 Methods of obtaining active antisense compounds |
| 02/19/2003 | EP1283907A1 Cancer diagnosis method |
| 02/19/2003 | EP1283906A1 Epigenetic sequences for esophageal adenocarcinoma |
| 02/19/2003 | EP1283905A2 Diagnosis of diseases associated with the cell cycle |
| 02/19/2003 | EP1283904A2 Cancer diagnosis using cell-sorting and gene-expression-profiles |
| 02/19/2003 | EP1283903A1 Drug screening systems and assays |
| 02/19/2003 | EP1283902A1 Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof |
| 02/19/2003 | EP1283901A1 Method and reagent kit for determining activity of 5'-nucleotidase |
| 02/19/2003 | EP1283899A1 New method and device |
| 02/19/2003 | EP1283897A2 Gene responsible for stargardt-like dominant macular dystrophy |
| 02/19/2003 | EP1283889A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/19/2003 | EP1283883A1 Treatment of cancer and neurological diseases |
| 02/19/2003 | EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/19/2003 | EP1283880A1 Antiviral antisense therapy |
| 02/19/2003 | EP1283878A2 Receptor-based interaction trap |
| 02/19/2003 | EP1283870A1 Novel cell systems having specific interaction of peptide binding pairs |
| 02/19/2003 | EP1283868A2 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 02/19/2003 | EP1283849A2 Human receptor proteins; related reagents and methods |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283675A1 Methods of modulating the activity of mura |
| 02/19/2003 | EP1283668A1 Nucleic acids that control plant development |
| 02/19/2003 | EP1092046A4 Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule |
| 02/19/2003 | EP1056777A4 Ligand receptors and uses therefor |
| 02/19/2003 | EP0910668A4 Methods for detection of rearranged dna |
| 02/19/2003 | EP0871764B1 Screening method |
| 02/19/2003 | EP0799421B1 Differential timing method for detecting multiple analytes in a test sample |
| 02/19/2003 | CN1398350A Method of measuring lipid components and method of examining renal failure |
| 02/19/2003 | CN1398300A Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 02/19/2003 | CN1398299A BZIP type transcripton factors regulating expression of rice storage protein |